Growth in a single broth microdilution well containing gentamicin at a concentration of 500 ,ug/ml predicted high-level resistance to gentamicin (MIC, -2,000 ,ug/ml) in 505 of 508 clinical isolates of enterococci. Failure to achieve synergistic killing with the combination of penicillin and an aminoglycoside was demonstrated with 100% specificity in 20 strains which showed resistance to 500 ,ug of gentamicin per ml. We recommend this procedure be adopted as a routine screening test to detect high-level aminoglycoside resistance in enterococci.
Enterococci are important causes of community-acquired and nosocomial infections (2, 12) . Penicillin-and-aminoglycoside combination therapy is recommended for serious enterococcal infections (2, 5) . High-level resistance to gentamicin (MIC, .2,000 ,ug/ml) is often associated with resistance to other aminoglycosides, and highly resistant strains show lack of synergistic killing by the combination of penicillin and gentamicin (1, 4) . The prevalence of high-level resistance to gentamicin in enterococci has increased since it was first reported in 1979 (1) (2) (3) (4) (8) . Organisms in the log phase of growth were inoculated into Mueller-Hinton broth (Difco Laboratories, Detroit, Mich.) supplemented with 50 mg of Ca2+ per ml and 25 mg of Mg2+ per ml for a final concentration of 5 x 105 CFU/ml. High-level aminoglycoside resistance was defined by an MIC of .2,000 ,ug/ml. A single microdilution well containing gentamicin at a concentration of 500 Fxg/ml was used to detect high-level resistance; 5,797 isolates were screened. All isolates which showed growth in the 500-,ug/ml well were subsequently cultured on brain heart infusion agar containing concentrations of aminoglycosides of 2,000 p.g/ml, since this method was previously shown to confirm high-level resistance (4, 5) .
Synergy of the combination of penicillin and an aminoglycoside was evaluated by time-kill curves. The methods and criteria for determining synergy were described previously (5, 11) . Aminoglycoside concentrations were chosen to reflect clinically achievable concentrations in serum and did not exceed 10 ,ug/ml for gentamicin and 25 ,ug/ml for streptomycin when used to test resistant strains. Synergy was defined by a .2-logl0 reduction in CFU per milliliter at 24 h with the combination of antibiotics compared with penicillin or an aminoglycoside alone. Ten isolates were selected for use as controls in the synergy experiments; for five isolates, gentamicin MICs were -64 Ftg/ml, but these isolates were resistant to high levels of streptomycin. The other five strains were inhibited by concentrations of <64 ,ug of both gentamicin and streptomycin per ml.
Of 508 isolates which showed growth in the single 500-,ug/ml-concentration microdilution well, 505 exhibited highlevel resistance to gentamicin by agar dilution; for the other 3 isolates, gentamicin MICs ranged from 500 to 1,000 ,ug/ml. Of the 505 isolates with high-level resistance to gentamicin, 499 also showed high-level resistance to all aminoglycosides except spectinomycin. The other six isolates showed high-J. CLIN. MICROBIOL. level resistance to amikacin, gentamicin, kanamycin, neomycin, netilmicin, and tobramycin; streptomycin MICs ranged from 125 to 250 ,ugIml. For all 508 isolates, spectinomycin MICs ranged from 16 to 64 j±g/ml.
Synergy was evaluated with 37 isolates. The 10 strains for which gentamicin MICs were c64 ,ug/ml showed penicillingentamicin synergy. There was no synergy of killing when penicillin and streptomycin were tested in combination against the five isolates for which gentamicin MICs were c64 ,ug/ml and streptomycin MICs were .2,000 ,g/ml. All isolates for which streptomycin MICs were 125 to 250 ,ug/ml and which showed high-level resistance to amikacin, kanamycin, gentamicin, neomycin, netilmicin, and tobramycin also failed to show synergism by penicillin and streptomycin or gentamicin. Twenty strains for which spectinomycin MICs were c64 ,ug/ml but which showed high-level resistance to all other aminoglycosides were tested with penicillin in combination with gentamicin, streptomycin, or spectinomycin. Each combination failed to show synergism. The positive predictive value of the test for high-level gentamicin resistance was 99.4%. Lack of synergy of penicillin with gentamicin, streptomycin, or spectinomycin was predicted with 100% specificity for the isolates tested.
The results of this investigation show that a single broth microdilution well containing gentamicin at a concentration of 500 ,ug/ml predicts both resistance at 2,000 ,ug/ml and lack of synergy of penicillin in combination with gentamicin or streptomycin. Various methods are used in clinical microbiology laboratories for routine susceptibility testing of enterococci, including disk diffusion and standardized microdilution tests. However, neither of these methods screens for high-level resistance to aminoglycosides. Most clinical microbiology laboratories use standardized microdilution systems for routine susceptibility testing. Concentrations of gentamicin for susceptibility testing of enterococci on the microdilution plate usually do not exceed 8 to 64 ,ug/ml. These levels do not detect high-level resistance, which has a good correlation with lack of synergy of penicillin-andaminoglycoside combinations. Aminoglycoside disk susceptibility screening for high-level resistance has been described previously (9, 10) , but preparation of disks is cumbersonie; in addition, there is poor correlation between MIC and zone size with Kirby-Bauer disk diffusion (9) . Aminoglycoside disk testing of enterococci is also not recommended by the National Committee for Clinical Laboratory Standards (7). High-level resistance to aminoglycosides has been screened by using a single tube dilution of 2,000 ,ug of streptomycin per ml, but agar or tube dilution methods are cumbersome to perform as routine screening tests. Tests for synergy of killing are also difficult to perform on a routine basis.
